Allogeneic UCB-derived CAR-T for SLE

Clinical trial NCT07274059 · RECRUITING

Trial details

NCT number: NCT07274059
Sponsor: Chengdu Ucello Biotechnology Co., Ltd.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

SLE - Systemic Lupus Erythematosus

Start date: 2025-03-26
Primary completion: 2035-12-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.